Inovio Pharmaceuticals Net Income 2006-2021 | INO
For a detailed definition, formula and example for Net Income, check out our new background page here.
Inovio Pharmaceuticals net income from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Inovio Pharmaceuticals Annual Net Income
(Millions of US $) |
| 2020 |
$-166 |
| 2019 |
$-119 |
| 2018 |
$-97 |
| 2017 |
$-88 |
| 2016 |
$-74 |
| 2015 |
$-29 |
| 2014 |
$-36 |
| 2013 |
$-66 |
| 2012 |
$-20 |
| 2011 |
$-15 |
| 2010 |
$-18 |
| 2009 |
$-24 |
| 2008 |
$-13 |
| 2007 |
$-11 |
| 2006 |
$-14 |
| 2005 |
$-26 |
Inovio Pharmaceuticals Quarterly Net Income
(Millions of US $) |
| 2021-06-30 |
$-82 |
| 2021-03-31 |
$-54 |
| 2020-12-31 |
$-24 |
| 2020-09-30 |
$19 |
| 2020-06-30 |
$-129 |
| 2020-03-31 |
$-33 |
| 2019-12-31 |
$-38 |
| 2019-09-30 |
$-23 |
| 2019-06-30 |
$-29 |
| 2019-03-31 |
$-29 |
| 2018-12-31 |
$-33 |
| 2018-09-30 |
$-25 |
| 2018-06-30 |
$-7 |
| 2018-03-31 |
$-32 |
| 2017-12-31 |
$-22 |
| 2017-09-30 |
$-34 |
| 2017-06-30 |
$-9 |
| 2017-03-31 |
$-23 |
| 2016-12-31 |
$-26 |
| 2016-09-30 |
$-21 |
| 2016-06-30 |
$-19 |
| 2016-03-31 |
$-8 |
| 2015-12-31 |
$-18 |
| 2015-09-30 |
$6 |
| 2015-06-30 |
$-6 |
| 2015-03-31 |
$-11 |
| 2014-12-31 |
$-7 |
| 2014-09-30 |
$-7 |
| 2014-06-30 |
$-11 |
| 2014-03-31 |
$-11 |
| 2013-12-31 |
$-15 |
| 2013-09-30 |
$-31 |
| 2013-06-30 |
$-11 |
| 2013-03-31 |
$-9 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$-7 |
| 2012-06-30 |
$-4 |
| 2012-03-31 |
$-8 |
| 2011-12-31 |
$-5 |
| 2011-09-30 |
$-5 |
| 2011-06-30 |
$-3 |
| 2011-03-31 |
$-2 |
| 2010-12-31 |
$-6 |
| 2010-09-30 |
$-1 |
| 2010-06-30 |
$-8 |
| 2010-03-31 |
$-2 |
| 2009-12-31 |
$-7 |
| 2009-09-30 |
$-3 |
| 2009-06-30 |
$-11 |
| 2009-03-31 |
$-3 |
| 2008-12-31 |
$-4 |
| 2008-09-30 |
$-2 |
| 2008-06-30 |
$-4 |
| 2008-03-31 |
$-3 |
| 2007-12-31 |
$-1 |
| 2007-09-30 |
$-3 |
| 2007-06-30 |
$-4 |
| 2007-03-31 |
$-4 |
| 2006-12-31 |
$-8 |
| 2006-09-30 |
$-3 |
| 2006-06-30 |
$-3 |
| 2006-03-31 |
|
| 2005-12-31 |
$-12 |
| 2005-09-30 |
$-3 |
| 2005-06-30 |
$-2 |
| 2005-03-31 |
$-9 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.481B |
$0.007B |
|
Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.
|
